Related content

The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer

By Mizutani Y.   Wada H.   Fukushima M.   Yoshida O.   Ukimura O.   Kawauchi A.   Miki T.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 569-575

Elsevier

Access to resources Recommend Favorite

Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells

By Takechi T.   Fujioka A.   Matsushima E.   Fukushima M.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1271-1277

Elsevier

Access to resources Recommend Favorite

Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese population

By Hsiao Hui-Hua   Yang Ming-Yu   Chang Jan-Gowth   Liu Yi-Chang   Liu Ta-Chih   Chang Chao-Sung   Chen Tyen-Po   Lin Sheng-Fung  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Significance of Intratumoral TS Levels and DPD Activity in Breast Cancer

By Miyashita Masaru   Yoshimura Hisashi   Hatta Ken   Tachibana Shiro   Kubota Maki   Takahashi Hiroshi   Yamazaki Yoshisada   Maeda Kousaku   Okita Yutaka   Takao Shintaro  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 407-411

Sunmedia

Access to resources Recommend Favorite

DPYD*2A mutation: the most common mutation associated with DPD deficiency

By Saif M.   Ezzeldin Hany   Vance Katisha   Sellers Sandra   Diasio Robert  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 503-507

Springer Publishing Company

Access to resources Recommend Favorite